Northeast Bioanalytical Laboratories
Northeast Bioanalytical Laboratories is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Randomized, Placebo-controlled, Parallel Phase 2a Dose-ranging Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors CLEER Trial (Chemotherapy Longevity by Evading EGFR Inhibitor Reactions)
Sponsor Hoth Therapeutics Inc.
- Start (EU)
- Latest update
- Estimated end
An Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Sponsor Curis Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 2 Study of Emavusertib in Combination with an Approved Bruton Tyrosine Kinase Inhibitor in Patients with Chronic Lymphocytic Leukemia and Other B-cell Malignancies
Sponsor Curis Inc.
- Start (EU)
- Latest update
- Estimated end
A Phase 1/2A, Open Label Dose Escalation and Cohort Expansion Study of Orally Administered CA-4948 (IRAK4i) as a Monotherapy in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Sponsor Curis Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Northeast Bioanalytical Laboratories?
The 2026-10-09 snapshot links Northeast Bioanalytical Laboratories to 4 distinct CTIS trials. Recorded services include Laboratory services, PK Analysis, PK processing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Northeast Bioanalytical Laboratories?
Therapeutic-area tags are not recorded in this snapshot. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Northeast Bioanalytical Laboratories conducted?
The linked trials record locations in 7 countries, including Spain, France, Italy, Poland, Czechia. These are trial locations, not confirmed office locations or countries where Northeast Bioanalytical Laboratories delivered services.
What can this page tell me about Northeast Bioanalytical Laboratories's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Northeast Bioanalytical Laboratories. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Northeast Bioanalytical Laboratories LLC